Double Medical Financials
| 002901 Stock | 35.94 0.30 0.83% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 97.1 M | 102.3 M |
|
|
Double | Select Account or Indicator |
Understanding current and past Double Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Double Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Double Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Double Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Double Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Double Medical's management manipulating its earnings.
Double Medical Stock Summary
Double Medical competes with Agricultural Bank, Industrial, Bank of China, China Construction, and China Merchants. Double Medical is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE1000032W7 |
| Business Address | No 18, Hongdong |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.double-medical.com |
| Phone | 86 59 2608 3018 |
You should never invest in Double Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Double Stock, because this is throwing your money away. Analyzing the key information contained in Double Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Double Medical Key Financial Ratios
Double Medical's financial ratios allow both analysts and investors to convert raw data from Double Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Double Medical over time and compare it to other companies across industries.| Revenue | 1.53 B | ||||
| Gross Profit | 1.28 B | ||||
| EBITDA | 282.18 M | ||||
| Net Income | 58.97 M | ||||
| Total Asset | 4.64 B |
Double Medical Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Other Liab | 30.7M | 59.6M | 61.8M | 56.1M | 64.5M | 48.1M | |
| Net Tangible Assets | 1.4B | 1.7B | 2.0B | 2.3B | 2.6B | 1.5B | |
| Retained Earnings | 1.3B | 1.6B | 1.2B | 1.3B | 1.5B | 920.1M | |
| Other Assets | 6.6M | 100.9M | 9.4M | 66.4M | 76.4M | 80.2M | |
| Common Stock | 401.9M | 402.3M | 402.2M | 405.1M | 465.9M | 429.3M | |
| Total Assets | 2.6B | 3.4B | 3.9B | 4.6B | 5.3B | 2.8B | |
| Other Current Liab | 180.8M | 289.1M | 16.7M | 21.3M | 24.5M | 23.3M | |
| Accounts Payable | 179.8M | 296.3M | 345.4M | 281.6M | 323.9M | 193.5M | |
| Cash | 562.9M | 410.2M | 992.7M | 1.2B | 1.4B | 737.2M | |
| Net Receivables | 290.9M | 444.2M | 324.7M | 242.4M | 278.8M | 241.7M | |
| Inventory | 542.0M | 670.2M | 987.4M | 1.2B | 1.4B | 1.4B | |
| Other Current Assets | 21.7M | 36.0M | 13.0M | 26.1M | 23.4M | 28.8M | |
| Total Liab | 503.7M | 791.5M | 831.1M | 1.5B | 1.7B | 1.8B | |
| Total Current Assets | 2.0B | 2.4B | 2.7B | 3.2B | 3.6B | 2.0B | |
| Intangible Assets | 121.7M | 148.6M | 143.2M | 136.9M | 157.5M | 93.4M | |
| Net Invested Capital | 2.1B | 2.5B | 3.0B | 3.6B | 4.2B | 2.5B | |
| Net Working Capital | 1.5B | 1.7B | 2.0B | 2.0B | 2.3B | 1.7B | |
| Capital Stock | 402.3M | 402.2M | 405.1M | 414.0M | 476.1M | 447.3M |
Double Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Income Tax Expense | 62.6M | 90.3M | 94.9M | 111.0M | 127.7M | 75.9M | |
| Minority Interest | 30.0M | (18.2M) | (17.0M) | (27.4M) | (24.6M) | (23.4M) | |
| Tax Provision | 94.9M | 111.0M | 37.9M | 13.4M | 12.1M | 11.5M | |
| Net Interest Income | 23.6M | 13.7M | 17.6M | 22.4M | 25.8M | 16.3M | |
| Interest Income | 23.7M | 14.4M | 21.0M | 29.9M | 34.4M | 17.9M | |
| Total Revenue | 1.6B | 2.0B | 1.4B | 1.5B | 1.8B | 1.3B | |
| Gross Profit | 1.4B | 1.7B | 1.1B | 1.0B | 1.2B | 1.1B | |
| Operating Income | 708.7M | 818.0M | 116.0M | 113.6M | 102.3M | 97.1M | |
| Ebit | 406.9M | 489.9M | 633.1M | 717.4M | 825.1M | 518.1M | |
| Research Development | 128.0M | 167.1M | 256.7M | 285.3M | 328.1M | 344.5M | |
| Cost Of Revenue | 224.2M | 311.1M | 333.9M | 492.2M | 566.1M | 594.4M | |
| Income Before Tax | 709.6M | 802.5M | 147.5M | 99.7M | 89.8M | 85.3M | |
| Net Income | 605.7M | 673.3M | 92.6M | 59.0M | 53.1M | 50.4M | |
| Ebitda | 591.7M | 759.1M | 873.9M | 246.1M | 283.0M | 268.8M |
Double Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Double Medical's current stock value. Our valuation model uses many indicators to compare Double Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Double Medical competition to find correlations between indicators driving Double Medical's intrinsic value. More Info.Double Medical Technology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Double Medical Technology is roughly 2.95 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Double Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Double Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Double Medical Technology Systematic Risk
Double Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Double Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Double Medical Technology correlated with the market. If Beta is less than 0 Double Medical generally moves in the opposite direction as compared to the market. If Double Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Double Medical Technology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Double Medical is generally in the same direction as the market. If Beta > 1 Double Medical moves generally in the same direction as, but more than the movement of the benchmark.
Double Medical Technology Other Liab Over Time
Double Medical Thematic Clasifications
Double Medical Technology is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Double Medical January 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Double Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Double Medical Technology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Double Medical Technology based on widely used predictive technical indicators. In general, we focus on analyzing Double Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Double Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.71 | |||
| Information Ratio | 0.0048 | |||
| Maximum Drawdown | 12.25 | |||
| Value At Risk | (2.33) | |||
| Potential Upside | 3.3 |
Complementary Tools for Double Stock analysis
When running Double Medical's price analysis, check to measure Double Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Double Medical is operating at the current time. Most of Double Medical's value examination focuses on studying past and present price action to predict the probability of Double Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Double Medical's price. Additionally, you may evaluate how the addition of Double Medical to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |